IHH Healthcare Engages Mitsui to Facilitate Talks with Daiichi Sankyo in ₹11,800 Crore Dispute
IHH Healthcare seeks its investor Mitsui's help to set up talks with Daiichi in a ₹11,800 crore dispute
The Economic TimesImage: The Economic Times
IHH Healthcare, based in Malaysia, has sought assistance from its major shareholder Mitsui to initiate discussions with Japanese pharmaceutical company Daiichi Sankyo regarding an ongoing ₹11,800 crore legal dispute. Both companies are currently involved in parallel legal proceedings in India and Japan, while IHH remains focused on its operational goals.
- 01IHH Healthcare is seeking Mitsui's help to negotiate with Daiichi Sankyo.
- 02The dispute involves ₹11,800 crore in damages and is tied to Daiichi's issues with the Singh brothers.
- 03IHH insists it is a bystander in the legal conflict and is focused on its operations.
- 04Executives express confidence in the legal process while remaining open to out-of-court resolutions.
- 05Ongoing court proceedings are taking place in both Indian and Japanese courts.
Advertisement
In-Article Ad
IHH Healthcare, a hospital group headquartered in Malaysia, has reached out to its largest shareholder, Mitsui, to assist in discussions with Japanese drugmaker Daiichi Sankyo amid a significant legal dispute involving ₹11,800 crore in damages. The ongoing conflict is rooted in Daiichi's fallout with the Singh brothers, leading to legal actions in both Indian and Japanese courts. IHH's group CEO, Prem Kumar Nair, indicated a willingness to explore out-of-court negotiations, signaling the company's desire to resolve the matter amicably. Despite the litigation, IHH remains focused on its operational goals, with Ashok Pandit, the group's chief corporate officer, asserting that the dispute does not distract from their business objectives. Both executives emphasized their commitment to following the legal process while being open to potential negotiations, reflecting a rational approach to the situation. The ongoing court proceedings in the Delhi High Court are expected to shape the next steps for IHH as they navigate this complex legal landscape.
Advertisement
In-Article Ad
The outcome of this dispute could affect IHH Healthcare's operations and financial stability in India, influencing investor confidence and future investments.
Advertisement
In-Article Ad
Reader Poll
Do you think IHH Healthcare should pursue an out-of-court settlement with Daiichi Sankyo?
Connecting to poll...
Read the original article
Visit the source for the complete story.

